The focus of this module is pre-clinical drug development in pharmaceutical biotechnology. It will cover small molecule drug discovery, including target identification, assay creation, hit-to-lead, and proof-of-concept pre-clinical method development. Additionally, it will encompass sourcing drug development compounds and projects through technology audits and licensing-in. Finally, the module will examine the science behind, and clinical application of, recent successful drug candidates.
20 Masters level credits
Module Attendance Required
TBC, 30 hours contact time with lectures and small group teaching sessions
This module will require a 2500 word journal report worth 30%, a poster presentation also worth 30% and a short answer MCQ exam worth 40%
Academics involved in the delivery of this module
- Dr. Paul Foster (Deputy Programme Lead, Module Lead, and Lecturer in Molecular Endocrinology) – University of Birmingham
- Prof. Nick Barnes (Programme Lead and Professor of Neuropharmacology) – University of Birmingham
- Prof. Benjamin Wilcox (Professor of Molecular Immunology) – University of Birmingham
- Dr. Gareth Lavery (BBSRC David Phillips Fellow) – University of Birmingham
- Dr. Kevin Whitehead (Lecturer in Neuropharmacology) – University of Birmingham
- Dr. Christopher Ireson (Group Leader – Functional Pharmacology) – Cancer Research Technologies Ltd. UK.
- Dr. Richard Foster (MCCB Technology Group Leader) – Leeds University
- Dr. Laura Gathercole (Deputy Module Lead and Research Fellow) – University of Birmingham
How to register/apply
Contact our Course Administrator:
(0121) 415 8118
Please rest assured that we will make all reasonable efforts to provide you with the courses, services and facilities described. However, it may be necessary to make changes due to significant disruption, for example in response to COVID-19.
Information for future students and applicants
Coronavirus (COVID-19) latest updates and FAQs for future students and offer-holdersVisit our FAQs